Craft

Lepu Biopharma

Stock Price

$4.9

2024-05-17

Market Capitalization

$8.2 B

2024-05-17

Revenue

¥15.6 M

FY, 2022

Lepu Biopharma Summary

Company Summary

Overview
Lepu Biopharma is a biopharmaceutical company that focuses on oncology therapeutics. It develops a pipeline of drug candidates including ADCs, oncolytic virus drugs, and immunotherapies at clinical and pre-clinical stages.
Type
Public
Status
Active
Founded
2018
HQ
HK | view all locations
Website
https://www.lepubiopharma.com/
Sectors

LocationsView all

1 location detected

  • Hong Kong Island HQ

    Hong Kong

    183 Queen's Rd E, Wan Chai

Lepu Biopharma Financials

Summary Financials

Revenue (H1, 2023)
¥153.6M
Gross profit (H1, 2023)
¥149.7M
Net income (H1, 2023)
(¥141.9M)
Cash (H1, 2023)
¥581.5M
EBIT (H1, 2023)
(¥157.2M)
Enterprise value
$8.4B

Footer menu